The ROE (Return on Equity) of Myriad Genetics Inc (MYGN) is -18.16%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -18.16% |
| 2023-12-31 | -33.62% |
| 2022-12-31 | -12.64% |
| 2021-12-31 | -2.81% |
| 2020-12-31 | -6.03% |
| 2020-06-30 | -6.03% |
| 2019-06-30 | -21.73% |
| 2018-06-30 | 0.42% |
| 2017-06-30 | 13.80% |
| 2016-06-30 | 2.26% |